Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
April 01, 2024 16:15 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully...
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
December 13, 2023 06:15 ET
|
Integra LifeSciences Holdings Corporation
The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the...
Surgical Navigation Systems Market Size Worth $2.45 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 24, 2023 14:13 ET
|
The Insight Partners
Pune, India, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Surgical navigation systems allow the surgeons to precisely track instrument position and then project while performing surgeries. The surgical...
ENT Devices Market is Expected to Reach $22.3 Billion | MarketsandMarkets.
August 08, 2023 04:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 08, 2023 (GLOBE NEWSWIRE) -- In the near future, the ENT Devices industry is poised for transformative advancements driven by emerging technologies, personalized healthcare approaches,...
ENT Devices Market Size Worth USD 29.56 Billion by 2030 at 6.20% CAGR – Report by Market Research Future (MRFR)
May 29, 2023 10:45 ET
|
Market Research Future
New York, USA, May 29, 2023 (GLOBE NEWSWIRE) -- ENT Devices Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “ENT Devices Market Information By...
ENT Devices Market worth USD 36 billion by 2030, says Global Market Insights Inc.
June 07, 2022 03:15 ET
|
Global Market Insights Inc.
Selbyville, Delaware, June 07, 2022 (GLOBE NEWSWIRE) -- ENT devices market value is expected to reach USD 36 billion by 2030, according to a new research report by Global Market Insights Inc....
Ear Infection Treatment Market Value Projected To Reach US$ 9.6 Billion By 2028 Covering Covid-19 Impact: Acumen Research and Consulting
August 05, 2021 11:10 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Ear Infection Treatment Market– Global Industry Analysis, Market Size,...
Ear Nose and Throat (ENT) Treatment Market Value Surpass To Reach US$ 30.2 Billion By 2028 Covering Covid-19 Analysis: Acumen Research and Consulting
August 03, 2021 10:20 ET
|
Acumen Research and Consulting
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The Global Ear, Nose, and Throat (ENT) Treatment Market is expected to grow at a CAGR of around 5.5% from 2021 to 2028 and expected to reach around US$...
Cross Keys Capital Advises Atlanta Allergy & Asthma Clinic on Partnership with Southern Ear, Nose, Throat & Allergy Partners
September 30, 2020 17:59 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Atlanta Allergy & Asthma Clinic ("Atlanta Allergy") in its partnership...
Lyra Therapeutics Presents Clinical Data Demonstrating LYR-210’s Local Anti Inflammatory Effects for the Treatment of Chronic Rhinosinusitis
September 10, 2020 18:00 ET
|
Lyra Therapeutics
Two additional presentations highlight supporting data for LYR-210’s clinical program covering key clinical endpoints for CRS and Lyra’s XTreo™ drug release performance Findings presented at the...